SUWZX
Price
$36.23
Change
+$0.29 (+0.81%)
Updated
Jul 3 closing price
Net Assets
4.51B
VSTSX
Price
$295.41
Change
+$2.52 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

SUWZX vs VSTSX

Header iconSUWZX vs VSTSX Comparison
Open Charts SUWZX vs VSTSXBanner chart's image
DWS Core Equity R6
Price$36.23
Change+$0.29 (+0.81%)
VolumeN/A
Net Assets4.51B
Vanguard Total Stock Mkt Idx Instl Sel
Price$295.41
Change+$2.52 (+0.86%)
VolumeN/A
Net Assets1.82T
SUWZX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SUWZX vs. VSTSX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUWZX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.82T vs. SUWZX (4.51B). VSTSX pays higher dividends than SUWZX: VSTSX (1.23) vs SUWZX (0.78). SUWZX was incepted earlier than VSTSX: SUWZX (11 years) vs VSTSX (9 years). SUWZX (0.48) is less costly to investors than VSTSX (0.01). SUWZX is a more actively managed with annual turnover of: 18.00 vs. VSTSX (2.00). SUWZX has a lower initial minimum investment than VSTSX: SUWZX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.91 vs. SUWZX (2.49). VSTSX return over 5 years is better than : 95.76 vs. SUWZX (41.64).
SUWZXVSTSXSUWZX / VSTSX
Total Expense Ratio0.480.014,800%
Annual Report Gross Expense Ratio0.480.014,800%
Fund Existence11 years9 years-
Gain YTD6.1796.42796%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.51B1.82T0%
Annual Yield % from dividends0.781.2364%
Returns for 1 year2.4913.9118%
Returns for 3 years34.9462.2156%
Returns for 5 years41.6495.7643%
Returns for 10 years58.86N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNI17.480.30
+1.75%
ATN International
ORMP2.180.02
+0.93%
Oramed Pharmaceuticals
DAVA15.500.06
+0.39%
Endava plc
PODD301.62N/A
N/A
Insulet Corp
TOVX0.44-0.01
-1.56%
Theriva Biologics Inc